◀ Back to RELA

APOA1 — RELA

Pathways - manually collected, often from reviews:

• BioCarta mechanism of gene regulation by peroxisome proliferators via ppara: PPAR-alpha/Transcription factors complex (PPARA-JUN_RELA_SP1) → PPRE-Regulated proteins (LPL/APOA1/CPT1A/HSD17B4/APOA2/ME1/ACOX1/NR1H3/FABP1/EHHADH) (transcription, inhibits)
  

Text-mined interactions from Literome

Morishima et al., J Biol Chem 2003 (Arteriosclerosis) : NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator activated receptor alpha
Beers et al., Biochemistry 2006 : These results suggest that TNF alpha suppresses apoAI promoter activity through both the MEK/ERK and JNK pathways but is not mediated by either p38 MAP kinase activity or NF-kappaB activation
Roumeguère et al., Prog Urol 2008 (Cardiovascular Diseases) : ApoA-1 production, which is recognized as a cardioprotective lipid fraction, is down regulated by NFkappaB activation in vitro
Wang et al., Cytokine 2010 : ApoA-I diminished LPS induced mCD14 expression ( P < 0.01 ) and NFkappaB nuclear translocation in THP-1 cells
Yin et al., J Atheroscler Thromb 2012 : In addition, apoA-I inhibited the sCD40L stimulated activation of nuclear factor-kB (NF-kB)